Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Buy
51
COGT Quote, Financials, Valuation and Earnings
Last price:
$37.82
Seasonality move
:
-19.09%
Day range:
$35.09 - $38.36
52-week range:
$3.72 - $43.73
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
55.99x
P/B ratio:
29.82x
Volume:
1.9M
Avg. volume:
2.5M
1-year change:
412.75%
Market cap:
$5.8B
Revenue:
--
EPS (TTM):
-$2.37
COGT Analysts' Consensus Rating
The 11 analysts providing 12-month price projections for Cogent Biosciences, Inc. shares anticipate an average target of $50.25, ranging from a low estimate of $34.00 to a high estimate of $67.00. This average target implies a growth of 32.97% compared to the current stock price of $37.79.
Consensus Price Target
$50.25
Highest Price Target
$67.00
Lowest Price Target
$34.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 5 | 8 | 9 |
| Hold | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
COGT Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Is Shopify Stock a Good Buy Now?
eCommerce technology platform Shopify (NASDAQ:SHOP) delivered impressive returns in 2025…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
67
Is GOOG Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Buy
53
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Alerts
Sell
37
TCOM alert for Jan 15
Trip.com Group Ltd. [TCOM] is down 17.03% over the past day.
Sell
39
DAVE alert for Jan 15
Dave, Inc. [DAVE] is down 12.42% over the past day.
Sell
43
VKTX alert for Jan 15
Viking Therapeutics, Inc. [VKTX] is up 11.83% over the past day.
